China is the second-largest equity market in the world by market capitalisation and the largest country weight in most emerging markets indices. For US investors, three ETFs dominate the dedicated China allocation space: the SPDR S&P China ETF (GXC), the iShares MSCI China ETF (MCHI), and the iShares China Large-Cap ETF (FXI).

The differences between these three funds — in index methodology, holdings breadth, sector concentration, VIE structure risk and liquidity — are significant enough to produce materially different return profiles even when Chinese equity markets are moving in the same direction. As of April 2026, China (GXC) trades at 11.03x forward earnings — a 35.6% discount to the MSCI ACWI at 17.12x, per CountryETFTracker ValuationCache data — making it one of the cheapest major equity markets in the world. But the choice of China ETF vehicle is consequential.

Key Facts at a Glanc

e

Data from CountryETFTracker ETFInfoCache and ValuationCache, April 2026.

The Index Differences: What Each Fund Actually Track

s

The three funds track fundamentally different indices — and this drives more of the return divergence than expense ratios.

GXC — SPDR S&P China ETF tracks the S&P China BMI (Broad Market Index), which is one of the most comprehensive China indices available to US-listed ETFs. It includes Chinese companies listed in Hong Kong (H-shares), on US exchanges as ADRs (Alibaba, JD.com, Baidu), and a selection of China A-shares accessible via Stock Connect. With approximately 900+ holdings, GXC provides the broadest exposure to the Chinese equity market of the three funds. It captures mid and small-cap Chinese companies that FXI and even MCHI may underweight.

MCHI — iShares MSCI China ETF tracks the MSCI China index, which covers large and mid-cap Chinese stocks accessible to international investors — including H-shares listed in Hong Kong, ADRs listed in the US, and China A-shares included in MSCI's phased A-share inclusion programme. MCHI is the most commonly used China ETF for institutional investors who benchmark to MSCI indices. With approximately 700+ holdings, it is less comprehensive than GXC but more diversified than FXI.

FXI — iShares China Large-Cap ETF tracks the FTSE China 50 Index — exactly 50 of the largest and most liquid Chinese stocks listed in Hong Kong (H-shares). FXI is by far the most concentrated of the three funds: 50 stocks versus 700-900+ in the other two. The concentration is extreme: the top 10 holdings represent approximately 55-60% of the portfolio. FXI is heavily weighted toward Chinese state-owned enterprises (SOEs) in financials, energy and telecommunications — sectors where government intervention is most direct and valuation discounts are most persistent.

Sector Composition: The Critical Divergenc

e

The sector composition differences between GXC/MCHI and FXI explain a significant portion of their return divergence:

GXC and MCHI are heavily weighted toward Chinese technology, consumer discretionary and healthcare — sectors dominated by Alibaba, Tencent, JD.com, Meituan and other private-sector tech companies. These are the Chinese companies whose earnings are most directly tied to domestic consumption growth and digital economy expansion.

FXI is dominated by Chinese state-owned financials (Bank of China, China Construction Bank, ICBC), energy (PetroChina, CNOOC) and telecommunications (China Mobile, China Unicom). These SOE-dominated sectors trade at deeply discounted valuations due to governance concerns, low ROE targets set by the state, and limited dividend growth.

The sector divergence creates a structural performance difference: in periods when Chinese tech outperforms (2017-2020), GXC and MCHI significantly outperform FXI. In periods when Chinese financials outperform (rate cycle turning points), FXI can close the gap.

The VIE Structure Risk: The Factor Every China ETF Investor Must Understan

d

All three China ETFs hold significant exposure to Chinese companies through Variable Interest Entity (VIE) structures. VIEs are legal structures that allow foreign investors to gain economic exposure to Chinese companies in restricted sectors (technology, education, media) without technically owning equity in the operating entity.

Chinese law prohibits direct foreign ownership in these sectors. VIEs are contractual arrangements — not equity ownership — that have never been explicitly validated under Chinese law and have never been tested in a Chinese court. The SEC has flagged VIE risk extensively in its regulatory filings.

The practical implication: if the Chinese government were to invalidate VIE structures — as it has threatened at various points in the past — the legal basis for foreign investors' claims on Alibaba, Tencent and JD.com profits would be eliminated. This is a tail risk, not a base case, but it is the most consequential country-specific regulatory risk in the global country ETF universe.

GXC and MCHI carry the highest VIE exposure due to their tech-heavy composition. FXI's SOE-heavy composition has lower VIE risk (SOEs do not typically use VIE structures) but higher direct state intervention risk.

Performance and Valuatio

n

China (GXC) is down -2.48% year-to-date through April 10, 2026 — one of the weaker performers in the country ETF universe despite its deep valuation discount. The underperformance reflects several concurrent headwinds: continued regulatory uncertainty in the technology sector, sluggish domestic consumption recovery post-COVID, geopolitical risk from US-China trade tensions, and the Iran war's indirect effects on Chinese energy import costs.

At 11.03x forward P/E, China trades at a 35.6% discount to the MSCI ACWI and a 44.7% discount to the US market (SPY at 19.96x). The discount reflects the structural risk premium investors demand for:

• VIE structure uncertainty
• Chinese Communist Party regulatory intervention risk
• Geopolitical risk (Taiwan Strait scenarios)
• Corporate governance concerns (SOE alignment vs shareholder value)
• Currency risk (CNY/USD)

The dividend yield for GXC is 2.48% — moderate relative to the valuation discount, reflecting China's historically low corporate payout ratios.

Which China ETF Is Right for Each Investor

?

GXC is the most analytically coherent choice for investors seeking comprehensive China exposure. The S&P China BMI covers the broadest range of Chinese equities — large, mid and small cap across all listing venues (H-shares, ADRs, A-shares). The 900+ holdings provide genuine diversification across China's economic structure rather than concentration in any single sector. At 0.59% expense ratio, cost is identical to MCHI.

MCHI is the preferred choice for investors who benchmark to MSCI indices (most institutional investors) or who want to ensure their China allocation is consistent with the MSCI EM index (where MCHI's underlying index determines country weights). MCHI is the most commonly used dedicated China ETF for institutional allocation.

FXI is the most appropriate for short-term tactical trading rather than strategic allocation. The 50-stock FTSE China 50 concentration provides a high-beta, high-liquidity expression of Chinese equity market direction — useful for macro traders taking directional views on Chinese markets. FXI's deep SOE concentration makes it a poor vehicle for investors seeking exposure to China's private-sector growth story. Its 0.74% expense ratio is also the highest of the three. FXI is the most widely traded China ETF by daily volume, making it the primary vehicle for derivatives and short-term positioning.

Explore live China ETF data, valuations and performance at countryetftracker.com/country-detail?ticker=GXC and countryetftracker.com/valuation.

Frequently Asked Question

s

What is the difference between GXC, MCHI and FXI?

GXC tracks the S&P China BMI (~900+ holdings, broadest coverage). MCHI tracks the MSCI China index (~700+ holdings, institutional standard). FXI tracks the FTSE China 50 (exactly 50 H-share large caps, most concentrated). GXC and MCHI are both appropriate for long-term strategic allocation. FXI is primarily a tactical trading vehicle.

Is China cheap enough to buy at 11x forward P/E?

China's 11.03x forward P/E represents a 35.6% discount to the MSCI ACWI and a 44.7% discount to the US market. The discount reflects genuine structural risks (VIE structure, regulatory intervention, geopolitical risk) that have persisted for years. Whether the discount compensates adequately for these risks is a risk tolerance question — but the valuation starting point is among the cheapest of any major liquid equity market globally.

Does FXI include Chinese tech companies?

FXI has limited technology exposure relative to GXC and MCHI. The FTSE China 50 focuses on the largest H-share listed companies, which are dominated by SOE financials and energy. Alibaba and Tencent are included in FXI but at lower weights than in GXC or MCHI, which more fully capture the private-sector tech economy.

What is a VIE structure and why does it matter for China ETF investors?

A Variable Interest Entity (VIE) is a legal structure that allows foreign investors to gain economic exposure to Chinese companies in sectors where direct foreign ownership is prohibited by Chinese law. VIE arrangements are contractual, not equity ownership, and have not been validated under Chinese law. If China were to invalidate VIE structures, the legal basis for foreign claims on Chinese tech company profits could be eliminated — a tail risk that all three China ETFs carry to varying degrees.